Study Finds Possibility of New Ways to Treat, Manage Epilepsy Seizures
New findings from the University of Kentucky demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.
Epilepsy is one of the most common neurological disorders and around one-third of epilepsy patients do not respond well to anti-seizure drugs. Until now, it was believed that the cause and effect of epilepsy was merely based on a dysfunction in the brain’s neurons. However, recent findings suggest that epilepsy can be caused by many other factors, including a dysfunctional blood-brain barrier. Essentially, seizures erode the lining of capillaries in the brain which plays a role in letting nutrients in and keeping toxins out. This can result in a “leaky” blood-brain barrier, which leads to more seizures, resulting in epilepsy progression.
Björn Bauer’s lab at the UK College of Pharmacy collaborated with Sanders-Brown Center on Aging scientists to conduct research focused on this barrier leakage. Bauer and colleagues hypothesized that glutamate, released during seizures, mediates an increase in certain enzymes and activity levels, thereby contributing to barrier leakage.
Click here to read more.
NeuroSafe 2019 Symposium
Aug. 8-9, 2019; Minneapolis
SNSA Congress 2019
Aug. 8-11, 2019; Cape Town, South Africa
2019 Managing Coding and Reimbursement Challenges
Aug. 22-24, 2019; Rosemont, Ill.
2019 From Cranial to Spine: An Overview of Neurosurgical Topics for the Advanced Practice Provider
Aug. 28-31, 2019; Orlando, Fla.
Sept. 8-11, 2019; Leuven, Belgium